Investors File Class Action Lawsuit Against Sana Biotechnology Over Alleged Securities Violations
NEW YORK — Bronstein, Gewirtz & Grossman, LLC, a law firm with national recognition, has announced the filing of a class action lawsuit against Sana Biotechnology, Inc. and specific officers within the company. The litigation targets alleged violations of federal securities laws, focusing on the period between March 17, 2023, and November 4, 2024. The lawsuit accuses Sana, a company listed on NASDAQ under the stock symbol SANA, of disseminating materially false and misleading statements about its business operations and financial health. The core of the allegations lies in the assertion that Sana misled investors … Read more